NUCLEOLIN and cancer: Another study reported that AS1411-treatment of several cancer cell lines, including MDA-MB-231 and MDA-MB-468 TNBC cells, caused a type of non-apoptotic cell death characterized by hyperstimulation of macropinocytosis, and suggested a novel role for NCL in limiting the activation of Rac1, a driver of macropinocytosis [81].